CH299535A - Process for the production of an ether of (+) - 3-oxy-N-methyl-morphinans. - Google Patents

Process for the production of an ether of (+) - 3-oxy-N-methyl-morphinans.

Info

Publication number
CH299535A
CH299535A CH299535DA CH299535A CH 299535 A CH299535 A CH 299535A CH 299535D A CH299535D A CH 299535DA CH 299535 A CH299535 A CH 299535A
Authority
CH
Switzerland
Prior art keywords
methyl
oxy
ether
production
morphinan
Prior art date
Application number
Other languages
German (de)
Inventor
F Hoffmann- Aktiengesellschaft
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CH299535A publication Critical patent/CH299535A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Description

  

  Verfahren zur Herstellung     eines    Äthers des     (+)-3-Oxy-N-methyl-morphinans.       Es wurde gefunden, dass die in der Äther  gruppe mehr als 1     C-Atom    enthaltenden  Äther des     (+)-3-Oxy-N-methyl-morphinans     und deren Salze     wertvolle    hustenlindernde  Mittel sind und gegenüber den     racemischen     und den (-)-Verbindungen den     Vorteil     haben, dass sie die bei     Hustenmitteln    uner  wünschte     analgetischeWirkung    nicht besitzen.  



  Man kann diese Äther und deren Salze       erfindungsgemäss    dadurch     gewinnen,    dass  man     (+)-3-Oxy-N-methyl-morphinan    mit  einem für die Einführung von mehr als  1     C-Atom    enthaltenden,     Alkyl-    und     Alkenyl-          resten    geeigneten     Verätherungsmittel    behan  delt und,     gewünschtenfalls,        die        irrgesättigten     Äther hydriert.  



  Als     Verätherungsmittel        verwendet    man  vorzugsweise eine Verbindung der Formel  
EMI0001.0023     
    wobei     R1,    R2 und R3 gleiche oder ver  schiedene niedere     Alkyl-    oder     Alkenyl-          reste    bedeuten,  wobei mindestens einer von ihnen - und  zwar der nach J. von     Braun    (Liebigs Annalen  der Chemie, Band 382, [1911], Seite 5) in  Reaktion tretende -mindestens zwei     C-Atome     enthält.

      Aus den     Alkenyläthern    können durch       Hydrierung    die entsprechenden     gesättigten          Alkyläther    hergestellt werden. Die neuen  Äther geben mit anorganischen oder organi  schen Säuren wasserlösliche Salze. Sie sollen  als Heilmittel Verwendung finden.  



  Gegenstand des Patentes ist nun ein Ver  fahren zur Herstellung von<B>(+)</B>     -3-Propyloxy-          N-methyl-morphinan,    das dadurch gekenn  zeichnet ist, dass man (+)     -3-Oxy-N-methyl-          morphinan    mit einem     Verätherungsmittel    der  Formel  
EMI0001.0039     
         worin        R1    und R2 niedere     Alkyl-    oder       Alkenylreste        und        R3    einen     Allylrest    be  deuten,  behandelt,     und    das entstandene (+     )

  -3-Allyl-          oxy-N-inethyl-morphinan    hydriert.  



  <I>Beispiel:</I>  48,2 Gewichtsteile     Phenyl-allyl-dimethyl-          ammoniumbromid    werden in 50 Gewichtstei  len     iNethanol    gelöst und mit 41 Gewichtsteilen       methylalkoholischer    Kalilauge     (27,7prozentig)     und 40 Raumteilen     Toluol    versetzt.

   Das ent  standene     Kaliumbromid        wird        unter        Feuchtig-          keits-    und     Kohlensäureausschluss        abfiltriert.         25,7 Gewichtsteile     (+)-3-Oxy-N-methyl-          morphinan    werden in 800 Raumteilen     Toluol     gelöst und, um die     Lösung    wasserfrei zu  machen, 250 Raumteile     Toluol        abdestilliert,     abgekühlt und hierauf die     Allylierungslauge     zugefügt.

   Die     Lösung    wird nun unter Rühren  aufgeheizt, wobei zuerst Methanol, dann ein  Gemisch von Methanol und     Toluol,    zuletzt       Toluol        abdestilliert.    Die Reaktionslösung     wird     nach dem Abkühlen mit eiskalter,     verdünnter     Natronlauge gewaschen. Der nach dem Ab  destillieren zurückbleibende Rückstand wird       im    Hochvakuum destilliert. Siedepunkt 139  bis 149  C/0,006 mm. Das     Hydrobromid    kri  stallisiert aus     Alkohol-Aceton    und schmilzt  bei 167-168  C; [a]     D    =+ 32,8  (c = 3 in  Wasser).  



  20,7 Gewichtsteile     (+)-3-Allyl-oxy-N-me-          thy        1-morphinan-hydrobromid    werden in 150  Raumteilen Methanol mit 6 Gewichtsteilen       Pd-Kohle        (51/o        Pd-Metall)    und Wasserstoff  hydriert.  



  Nachdem die berechnete Menge Wasser  stoff aufgenommen ist,. wird vom Katalysator  getrennt und eingeengt. Der Rückstand wird  in Wasser aufgenommen, mit Natronlauge  alkalisch gestellt, die Base in Äther aufgenom-         men    und der Äther     abdestilliert.    Das (+)     -3-          Propyloxy-N-methyl-morphinan    bildet. ein       Tartrat,    welches mit 2     Mol    Kristallwasser  unter Sintern bei 98-105  C schmilzt;  [a] 20 = +32,1.6  (c = 3 in Methanol).



  Process for the production of an ether of (+) - 3-oxy-N-methyl-morphinans. It has been found that the ethers of (+) - 3-oxy-N-methyl-morphinans and their salts containing more than 1 carbon atom in the ether group are valuable antitussive agents and compared to the racemic and the (-) - compounds have the advantage that they do not have the undesirable analgesic effect of cough suppressants.



  These ethers and their salts can be obtained according to the invention by treating (+) - 3-oxy-N-methyl-morphinane with an etherifying agent suitable for introducing more than 1 carbon atom containing alkyl and alkenyl radicals and, if desired, hydrogenating the unsaturated ethers.



  A compound of the formula is preferably used as the etherifying agent
EMI0001.0023
    where R1, R2 and R3 are identical or different lower alkyl or alkenyl radicals, at least one of them - namely that of J. von Braun (Liebigs Annalen der Chemie, Volume 382, [1911], page 5) in Reaction occurring - contains at least two carbon atoms.

      The corresponding saturated alkyl ethers can be prepared from the alkenyl ethers by hydrogenation. The new ethers give water-soluble salts with inorganic or organic acids. They are said to be used as remedies.



  The subject of the patent is now a process for the production of <B> (+) </B> -3-propyloxy- N-methyl-morphinane, which is characterized in that (+) -3-oxy-N- methyl morphinan with an etherifying agent of the formula
EMI0001.0039
         where R1 and R2 are lower alkyl or alkenyl radicals and R3 is an allyl radical, treated, and the resulting (+)

  -3-Allyl-oxy-N-ynethyl-morphinan hydrogenated.



  <I> Example: </I> 48.2 parts by weight of phenyl-allyl-dimethylammonium bromide are dissolved in 50 parts by weight of iNethanol and mixed with 41 parts by weight of methyl alcoholic potassium hydroxide solution (27.7 percent) and 40 parts by volume of toluene.

   The resulting potassium bromide is filtered off with exclusion of moisture and carbon dioxide. 25.7 parts by weight of (+) - 3-oxy-N-methylmorphinane are dissolved in 800 parts by volume of toluene and, in order to render the solution anhydrous, 250 parts by volume of toluene are distilled off, cooled and the allylation liquor is then added.

   The solution is then heated with stirring, with first methanol, then a mixture of methanol and toluene, and finally toluene being distilled off. After cooling, the reaction solution is washed with ice-cold, dilute sodium hydroxide solution. The residue remaining after distilling off is distilled in a high vacuum. Boiling point 139 to 149 C / 0.006 mm. The hydrobromide crystallizes from alcohol-acetone and melts at 167-168 C; [a] D = + 32.8 (c = 3 in water).



  20.7 parts by weight of (+) - 3-allyl-oxy-N-methy 1-morphinane hydrobromide are hydrogenated in 150 parts by volume of methanol with 6 parts by weight of Pd-carbon (51 / o Pd-metal) and hydrogen.



  After the calculated amount of hydrogen has been absorbed. is separated from the catalyst and concentrated. The residue is taken up in water, made alkaline with sodium hydroxide solution, the base is taken up in ether and the ether is distilled off. The (+) -3-propyloxy-N-methyl-morphinan forms. a tartrate which melts with 2 mol of crystal water with sintering at 98-105 C; [a] 20 = +32.1.6 (c = 3 in methanol).

 

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung von (+ )-3 Propyloxy-N-methyl-morphinan, dadurch ge kennzeichnet, dass man (+ ) -3-Oxy-N-methyl- morphinan mit einem Verätherungsmittel der Formel EMI0002.0033 worin R, und R2 niedere Alkyl- oder Alkenylreste und R.3 einen Allylrest be deuten, behandelt und das entstandene (+ ) -3-Allyl- oxy-N-methyl-morphinan hydriert. PATENT CLAIM: Process for the production of (+) -3 propyloxy-N-methyl-morphinan, characterized in that (+) -3-oxy-N-methyl-morphinan with an etherifying agent of the formula EMI0002.0033 where R, and R2 are lower alkyl or alkenyl radicals and R.3 is an allyl radical, treated and hydrogenated the (+) -3-allyl-oxy-N-methyl-morphinan. Die neue Verbindung bildet ein Tartrat, welches mit 2 Mol Kristallwasser unter Sin tern bei 98-105 C schmilzt; [a]D = + 32,16 (c = 3 in Methanol). The new compound forms a tartrate which melts with 2 mol of crystal water under sintering at 98-105 C; [a] D = + 32.16 (c = 3 in methanol).
CH299535D 1951-10-18 1951-10-18 Process for the production of an ether of (+) - 3-oxy-N-methyl-morphinans. CH299535A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH299535T 1951-10-18

Publications (1)

Publication Number Publication Date
CH299535A true CH299535A (en) 1954-06-15

Family

ID=4490349

Family Applications (1)

Application Number Title Priority Date Filing Date
CH299535D CH299535A (en) 1951-10-18 1951-10-18 Process for the production of an ether of (+) - 3-oxy-N-methyl-morphinans.

Country Status (1)

Country Link
CH (1) CH299535A (en)

Similar Documents

Publication Publication Date Title
DE2351281C3 (en) Aminophenylethanolamine derivatives, their production and use
CH299535A (en) Process for the production of an ether of (+) - 3-oxy-N-methyl-morphinans.
DE919468C (en) Process for the preparation of ethers of (+) - 3-oxy-N-methylmorphinans
DE1907403A1 (en) New asymmetrical diaryloxalamides and their use as stabilizers and UV absorbers for plastics
CH299103A (en) Process for the production of an ether of (+) - 3-oxy-N-methyl-morphinans.
AT221526B (en) Process for the preparation of new thioxanthene derivatives
CH304300A (en) Process for the production of an ether of (+) - 3-oxy-N-methyl-morphinans.
DE1470264C3 (en) Process for the preparation of 1-phenyl-1 - square brackets on thienyl- (2) square brackets to -carbinols
DE882092C (en) Process for the preparation of N-substituted polyamines
CH396941A (en) Process for the preparation of new secondary amines
AT230882B (en) Process for the production of 6-aminochryses
AT221504B (en) Process for the production of new basic phenol ethers and their salts
DE895454C (en) Process for the preparation of ª-dimethylaminoethyl benzhydryl ether
AT226716B (en) Process for the preparation of new, water-soluble compounds containing at least two epoxy groups
DE1493961B2 (en) l-Hydroxy-2-alkylamino-i-phenyläthanderivate their acid addition salts, process for their production and pharmaceutical preparations
CH615422A5 (en)
AT233016B (en) Process for the preparation of new iminodibenzyl derivatives
DE653073C (en) Process for the preparation of alkylaminoalkyl ethers of apoquinine
AT229292B (en) Process for the preparation of new basic substituted diphenylalkane derivatives and their salts
AT155800B (en) Process for the production of diamino alcohols.
AT254166B (en) Process for the preparation of new 5- (3&#39;-sec.Aminopropyl) -5H-dibenzo [a, d] cycloheptenes or the 10,11-dihydro derivatives thereof
DE1620206C (en) N-Cyclopropylmethyl-6,14-endo-ethanotetrahydronororipavine and their salts, processes for their preparation and pharmaceutical preparations containing these compounds
CH358081A (en) Process for the preparation of thioxanthenes
DE2155997B2 (en) Process for the preparation of furan compounds
DE1543995A1 (en) Process for the preparation of 5- (3-sec. Aminoalkylidene) -10,11-dihydro-5H-dibenzo [a, d] cycloheptenes